Bacchus Vascular

Bacchus Vascular

U.S. Peripheral Products | Covidien. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€24—35m (Dealroom.co estimates Apr 2007.)
Santa Clara United States (HQ)
  • Edit
DateInvestorsAmountRound
N/A

$5.7m

Late VC

$25.0m

Series D

$6.5m

Late VC

N/A

Acquisition
Total Funding€33.8m

Recent News about Bacchus Vascular

Edit
More about Bacchus Vascularinfo icon
Edit

Bacchus Vascular specializes in developing and providing advanced vascular devices designed to improve patient care. Operating in the medical technology sector, the company serves healthcare providers and institutions by offering a range of reliable, safe, and high-quality devices. Bacchus Vascular's business model revolves around the research, development, and commercialization of these medical devices, generating revenue through direct sales to hospitals and clinics. The company aims to address some of the most pressing challenges in healthcare by collaborating with industry experts and leveraging cutting-edge technology. Bacchus Vascular is committed to innovation and quality, ensuring that their products meet the highest standards of safety and efficacy. The company also emphasizes a collaborative and innovative culture, attracting top talent to drive its mission forward.

Keywords: vascular devices, patient care, medical technology, healthcare providers, innovation, quality, safety, collaboration, research, development.